Hans C. Noetzli

Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY.

Synthetech, Inc. manufactured organic chemicals. The firm’s products were used in drugs under development or on the market for the treatment of AIDS, cancer, cardiovascular and other diseases. The company was founded in 1981 and was headquartered in Albany, OR.

Patheon API Services, Inc. develops, tests and manufactures drugs. It also engages in the generation of process technology for new and existing drugs, and the production of Active Pharmaceutical Ingredients (APIs). The company was founded in 1996 and is headquartered in Florence, SC.

Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ.

Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004.